Table 2.

Multivariable analysis of risk factors for mortality after COVID-19 diagnosis.

	OR (95% CI)	p value
Age	1.07 (1.02–1.11)	0.003
Male sex	2.48 (1.01–6.07)	0.047
MF diagnosis	1.69 (0.61–4.66)	0.315
Chronic heart disease	2.18 (0.64–7.36)	0.210
Respiratory support	10.0 (2.94–34.0)	<0.001
ICU admission	4.93 (1.36–17.9)	0.015
Ruxolitinib administration	2.40 (0.72–8.02)	0.154
Ruxolitinib discontinuation	8.51 (1.14–63.4)	0.037

OR odds ratio, CI confidence interval, MF myelofibrosis, ICU intensive care unit.